Stock screenerAll disclosures →
EDGAR →
MGNX
Conviction 84HealthcareScan · Fri, Jun 26, 2026Bullish engulfing
MGNX$4.79+2.79%
ResistanceSupportVol 14Vol MA14 947.61K
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price4.79
Change+2.79%
Gap-0.11%
Rel volume1.21×
Avg volume831.09K
Avg $ vol3.6M
SMA 204.20
SMA 503.83
SMA 2002.40
Price vs 50+25.03%
Price vs 200+99.36%
MA stackbullish
50/200 cross—
Supertrendup · 3.85
RSI (14)67
MACD hist0.06
MACD crossbull · 3d
Stoch %K / %D77 / 73
ADX (14)36
+DI / −DI29 / 8
RSI divergence—
MACD divergence—
ATR %+6.69%
ADR %7.00%
52w high4.79
52w low1.19
From 52w high+0.00%
Above 52w low+302.52%
New 52w highYes
SqueezeOff
Bollinger width29.79%
%B0.97
Donchian pos77.17%
Donchian high5.08
Donchian low3.81
AVWAP (52w high)4.77
vs AVWAP high+0.32%
AVWAP (52w low)2.30
vs AVWAP low+108.42%
OBV trendUp
Chaikin MF (20)-0.06
Today vs 20d1.21×
Avg vol (14d)947.61K
Avg vol (20d)831.09K
Avg $ vol (20d)3.6M
Market cap—
RS 3m (vs SPY)+35.21%
RS 6m (vs SPY)+185.86%
RS line new highNo
Trend template8/8
Technical rank94.5
1 week+15.98%
1 month+9.36%
3 months+50.63%
6 months+199.37%
1 year+265.65%
YTD+197.52%
P/E-3.96
P/B13.94
P/S1.98
P/FCF-3.56
EPS-1.18
Div yield—
ROE-352.01%
ROA-34.25%
Debt/Eq—
Current1.90
EV/EBITDA-3.49
Gross margin—
Net margin-49.91%
Rev growth-0.31%
EPS growth-11.43%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value229.05M
Revenue20.77M
Net income-36.77M
Gross profit—
Free cash flow-82.95M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees293
ListedThu, Oct 10, 2013
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction84 / 100
Pattern quality—
Tech rank94.5 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MGNX
No recent disclosed trades by Congress in MGNX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MGNX · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
HEIDEN WILLIAM K Director · Stock Option (right to buy) · 2026-05-19 | Grant | 22K | $0 | 2026-05-19 | 2026-05-20 |
Jackson Scott Thomas Director · Stock Option (right to buy) · 2026-05-19 | Grant | 22K | $0 | 2026-05-19 | 2026-05-20 |
Koenig Scott Director · Stock Option (right to buy) · 2026-05-19 | Grant | 22K | $0 | 2026-05-19 | 2026-05-20 |
Liu Margaret Director · Stock Option (right to buy) · 2026-05-19 | Grant | 22K | $0 | 2026-05-19 | 2026-05-20 |
STUMP DAVID C Director · Stock Option (right to buy) · 2026-05-19 | Grant | 22K | $0 | 2026-05-19 | 2026-05-20 |
STUMP DAVID C Director · Restricted Stock Unit · 2026-05-19 | Grant | 3.75K | $0 | 2026-05-19 | 2026-05-20 |
Koenig Scott Director · Restricted Stock Unit · 2026-05-19 | Grant | 3.75K | $0 | 2026-05-19 | 2026-05-20 |
Ferrante Karen Jean Director · Restricted Stock Unit · 2026-05-19 | Grant | 3.75K | $0 | 2026-05-19 | 2026-05-20 |
Chhabra Meenu Director · Stock Option (right to buy) · 2026-05-19 | Grant | 22K | $0 | 2026-05-19 | 2026-05-20 |
HURWITZ EDWARD Director · Restricted Stock Unit · 2026-05-19 | Grant | 3.75K | $0 | 2026-05-19 | 2026-05-20 |
SEC filings
EDGAR filings in MGNX · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.